Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

216.56
Delayed Data
As of Apr 29
 -2.29 / -1.05%
Today’s Change
212.67
Today|||52-Week Range
340.34
-30.70%
Year-to-Date
3 Big Merger Deals That Regulators Challenged and What It Means
Apr 30 / TheStreet.com
Local politics can turn deal heroes to zeros
Apr 11 / FT.com
Better Buy: The Coca-Cola Co vs. PepsiCo, Inc.
Apr 29 / MotleyFool.com
M&A crackdown puts bond investors on edge
Apr 11 / FT.com
Jerome Dodson Sells Stake in Citrix Systems in st Quarter
Apr 28 / GuruFocus News
M&A splurge comes home to roost
Apr 08 / FT.com
Even the Fed Can't Make Stocks Budge
Apr 28 / TheStreet.com
M&A deals worth $370bn torpedoed by Obama administration
Apr 07 / FT.com
Pfizer (PFE) to Report Q1 Earnings: Will the Stock Surprise?
Apr 28 / Zacks.com
Pfizer chief's long quest for tax inversion ends in failure
Apr 06 / FT.com
Daniel Loeb warns of hedge fund 'killing field'
Apr 27 / FT.com
M&A failures: deep breaths
Apr 06 / FT.com
Tax Inversions: Explaining What They Are, How We Got Here and What's Next
Apr 26 / TheStreet.com
US Treasury shatters Pfizer chief Ian Read's merger dreams
Apr 06 / FT.com
Will the Next President Be as Tough on Mergers and Acquisitions as Obama?
Apr 26 / TheStreet.com
Pfizer merger collapse is serious failure of management
Apr 06 / FT.com
Treasury Department Was 'Targeting' Pfizer-Allergan Deal
Apr 26 / TheStreet.com
Pfizer: plan C
Apr 06 / FT.com
With New Treasury Department Rules, Is This the End of Tax Inversion Deals?
Apr 26 / TheStreet.com
Pfizer-Allergan merger scrapped after Obama cracks down on tax breaks
Apr 06 / CNNMoney.com
Cramer: Papa's Got a Brand New Bag, and Leaves Perrigo Holding the Old One
Apr 26 / TheStreet.com
Stocks: 5 things to know before the open
Apr 06 / CNNMoney.com
Weitz Funds Comments on Allergan
Apr 25 / GuruFocus News
Pfizer and Allergan abandon $160bn deal after US tax crackdown
Apr 06 / FT.com
Is Now the Time to Jump on Allergan?
Apr 25 / TheStreet.com
US tax crackdown provokes foreign fury
Apr 05 / FT.com
Celgene (CELG) Q1 Earnings: What's in Store for the Stock?
Apr 25 / Zacks.com
Hedge funds knocked by Allergan's fall
Apr 05 / FT.com
The week: April 25
Apr 24 / FT.com
US crackdown on inversions came 'out of left field'
Apr 05 / FT.com
3 Stocks We're Ready to Buy Again
Apr 22 / MotleyFool.com
Washington slams shut Pfizer's tax loophole
Apr 05 / FT.com
3 Value Stocks Near 52-Week Lows Worth Buying
Apr 20 / MotleyFool.com
Treasury's shot at tax inversions will cause collateral damage
Apr 05 / FT.com
What's Behind Synergy Pharmaceuticals' Soaring Shares Today
Apr 19 / MotleyFool.com
Tax inversions: bloody nightmare
Apr 05 / FT.com
3 Biggest Challenges Facing Lannett Company Inc. Stock
Apr 19 / MotleyFool.com
New U.S. tax rules throw $160 billion merger into doubt
Apr 05 / CNNMoney.com
Paulson's funds plunge nearly $2bn on Allergan and Valeant bets
Apr 19 / FT.com
Tax inversions: what the new rules mean
Apr 05 / FT.com
UK companies more likely to hire outside CEOs
Apr 18 / FT.com
Stocks: 5 things to know before the open
Apr 05 / CNNMoney.com
It's time for an outright ban on mega-transactions
Apr 13 / FT.com
Allergan plunges on inversion curbs, the transatlantic tax tussle and a disease that ...
Apr 05 / FT.com
Companies cannot escape nationalities and borders
Apr 13 / FT.com
Allergan plunges 22% on new tax inversion curbs
Apr 04 / FT.com
Deals may be scuttled but nothing can prevent the talent from migrating
Apr 11 / FT.com